Scholars Central

Conference abstractPublished 28 May 2018

Acute myeloid leukemia with characteristic molecular mutations

Authors: Ryan Robetorye

Mayo Clinic, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cytogenetic studies have traditionally played one of the most important roles for the classification and risk stratification of acute myeloid leukemia (AML). AML patients with a favorable risk cytogenetic profile are associated with relatively good responses to chemotherapy-based regimens and high complete remission rates. AML patients with unfavorable cytogenetic risk profiles require allogeneic stem cell transplantation to improve prognosis. However, most AML cases have an intermediate prognosis and include approximately 50% of AML cases that have a normal karyotype at diagnosis and cannot be further sub-classified based on cytogenetics. In recent years, several recurrent molecular mutations discovered in AML have been proposed to establish better classification of prognosis in the intermediate cytogenetic risk category. Recent revisions in the WHO- ‘Classification of tumors of hematopoietic and lymphoid tissues’ have resulted in adopting the provisional diagnostic entities- ‘AML with mutated CEBPA’ and ‘AML with mutated NPM1’ as distinct entities and adding ‘AML with mutated RUNX1’ as a provisional diagnostic entity. This presentation will focus on the characteristic clinicopathologic features of AML with mutations in the CEBPA, NPM1 and RUNX1 genes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGenetics & Molecular Biology
  • SubjectHaematology
  • BylineArticles whose byline prints “Ryan Robetorye”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels